Explore our news

02.12.2019

STADA to Become a Major Pharma Player in Ukraine by Acquiring Biopharma’s Pharmaceutical Prescription and Consumer Health Business

06.11.2019

Alvotech and STADA agree on strategic biosimilar partnership

Alvotech and STADA enter into a strategic collaboration for seven biosimilar candidates in Europe

06.11.2019

STADA recognized as “Company of the year, EMEA” for the second year in a row

05.11.2019

STADA invests $660 Million USD in Takeda’s OTC portfolio in Russia/CIS

to become a major player in these branded markets

04.11.2019

STADA to acquire Walmark

A leading Consumer Healthcare company in Central Europe

22.10.2019

Germans: Europe’s check-up champions expect their doctor to lend them an ear

STADA Health Report 2019

05.09.2019

European Day for Organ Donation and Transplantation

Opt-out solution would double number of organ donors in Germany

14.08.2019

STADA Delivers Strong First-Half 2019 Results

With reported sales growth of 11 percent in the first-half of 2019, STADA is performing well above the industry average.

Grippostad® C TV-Spot

Denn du fehlst, wenn du erkältet bist.

Hoggar® Night TV Spot

Einfach gut schlafen.

Hedrin®

und aus die Laus!

Nizoral®

Zur Behandlung von Kopfschuppen.

Nizoral®

Zur Behandlung von Kopfschuppen.

STADA on YouTube

Get in touch

For Journalists

STADA Arzrneimittel AG
Media Relations
61118 Bad Vilbel

Phone: +49(0) 6101 603-165

Fax: +49(0) 6101 603-215

press@stada.de

For Customers, Business Partners & general inquiries

STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel

Phone: +49(0) 6101 603-0

Fax: +49(0) 6101 603-215

info@stada.de

We use cookies to make our website more user-friendly and to continuously improve it. By continuing to use the website, you consent to the use of cookies. More information can be found in our Privacy Policy